NATASHA KHOKHAR: Open Payments
NPI 1871168286 · FRENCH CAMP, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $583
Food & beverage: $488Education: $95
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $195 |
| PFIZER INC. | 3 | $95 |
| Amgen Inc. | 3 | $81 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| AbbVie Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: Veozah, ELIQUIS, EVENITY, SHINGRIX, UBRELVY, REXULTI, Ozempic, GARDASIL 9.
Industry payments across CA — which companies pay providers there.
